XML 109 R110.htm IDEA: XBRL DOCUMENT v2.4.0.6
SCHEDULE I - CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Details 3) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2010
Sep. 30, 2010
Jun. 30, 2010
Mar. 31, 2010
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash Flows from Operating Activities                      
Net income $ 298 $ 168 $ 281 $ 223 $ 254 $ 312 $ 398 $ 296 $ 970 $ 1,260 $ 737
Loss (income) from discontinued operations, net of tax (13) (2) 4 71 26 2 (2) (2) 60 24 (1)
Net cash provided by (used in) operating activities                 2,178 1,847 (1,318)
Available-for-Sale securities:                      
Proceeds from sales                 888 1,519 5,630
Maturities, sinking fund payments and calls                 5,206 6,404 5,855
Purchases                 (7,236) (7,502) (17,815)
Purchase of other investments                 (422) (102) (14)
Purchase of land, buildings, equipment and software                 (250) (131) (83)
Acquisitions                   (866)  
Proceeds from sale of business 0               150    
Other, net                 (7) (15) 7
Net cash used in investing activities                 (1,146) (734) (6,373)
Cash Flows from Financing Activities                      
Repayments of debt                 (20) (354) (550)
Dividends paid to shareholders                 (212) (183) (164)
Repurchase of common shares                 (1,495) (582) (11)
Proceeds from issuance of common stock                     869
Issuance of debt, net of issuance costs                   744 491
Exercise of stock options                 66 113 6
Excess tax benefits from share-based compensation                 90 9 12
Other, net                   (5) (2)
Net cash provided by (used in) financing activities                 (1,111) (1,343) 4,545
Net decrease in cash and cash equivalents                 (80) [1] (236) [1] (3,131) [1]
Cash and cash equivalents at beginning of period       2,861 [1]       3,097 [1] 2,861 [1] 3,097 [1] 6,228 [1]
Cash and cash equivalents at end of period 2,781 [1]       2,861 [1]       2,781 [1] 2,861 [1] 3,097 [1]
Supplemental Disclosures:                      
Interest paid on debt                 201 231 251
Income taxes paid, net                 370 61 98
Non-cash financing activity:                      
Dividends declared but not paid 62               62    
Ameriprise Financial, Inc:
                     
Cash Flows from Operating Activities                      
Net income                 1,076 1,097 722
Equity in earnings of subsidiaries excluding discontinued operations                 (1,300) (1,202) (863)
Loss (income) from discontinued operations, net of tax                 60 24 (1)
Dividends received from subsidiaries                 1,210 796 204
Other operating activities, primarily with subsidiaries                 (231) 921 (90)
Net cash provided by (used in) operating activities                 815 1,636 (28)
Available-for-Sale securities:                      
Proceeds from sales                   31 29
Maturities, sinking fund payments and calls                 239 151 86
Purchases                 (22) (151) (139)
Purchase of other investments                   (32)  
Purchase of land, buildings, equipment and software                 (56) (32) (29)
Contributions to subsidiaries                 (128) (73) (233)
Return of capital from subsidiaries                 22 116 60
Acquisitions                   (866)  
Proceeds from sale of business                 150    
Repayment of loans to subsidiaries                 1,252 1,282 1,400
Issuance of loans to subsidiaries                 (1,312) (1,463) (1,599)
Other, net                 2 34 8
Net cash used in investing activities                 147 (1,003) (417)
Cash Flows from Financing Activities                      
Repayments of debt                 (14) (354) (550)
Dividends paid to shareholders                 (212) (183) (164)
Repurchase of common shares                 (1,495) (582) (11)
Proceeds from issuance of common stock                     869
Issuance of debt, net of issuance costs                   744 491
Exercise of stock options                 66 113 6
Excess tax benefits from share-based compensation                 90 9 12
Other, net                 (1) (2) (4)
Net cash provided by (used in) financing activities                 (1,566) (255) 649
Net decrease in cash and cash equivalents                 (604) 378 204
Cash and cash equivalents at beginning of period       1,316       938 1,316 938 734
Cash and cash equivalents at end of period 712       1,316       712 1,316 938
Supplemental Disclosures:                      
Interest paid on debt                 139 140 122
Income taxes paid, net                 334 2 4
Non-cash capital transactions to (from) subsidiaries                 (850) 14 331
Non-cash financing activity:                      
Dividends declared but not paid $ 62               $ 62    
[1] Cash and cash equivalents includes cash held for sale. See Note 24 for additional information.